tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
LGND is currently covered by 4 analysts with an average price target of $218.58. This is a potential upside of $17.23 (8.56%) from yesterday's end of day stock price of $201.35.
Ligand Pharmaceuticals's activity chart (see below) currently has 169 price targets and 111 ratings on display. The stock rating distribution of LGND is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 93.21% with an average time for these price targets to be met of 453 days.
Highest price target for LGND is $234, Lowest price target is $160, average price target is $211.25.
Most recent stock forecast was given by DOUGLAS MIEHM from RBC on 09-Nov-2025. First documented stock forecast 11-Feb-2014.
Currently out of the existing stock ratings of LGND, 8 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$234
$33.14 (16.50%)
$143
8 days ago
(09-Nov-2025)
5/6 (83.33%)
$24.71 (11.81%)
305
Buy
$220
$19.14 (9.53%)
$175
11 days ago
(06-Nov-2025)
10/11 (90.91%)
$17.52 (8.65%)
196
Buy
$231
$30.14 (15.01%)
12 days ago
(05-Nov-2025)
35/40 (87.5%)
$22.78 (10.94%)
620
Buy
$160
$-40.86 (-20.34%)
$150
11 months 2 days ago
(15-Dec-2024)
15/15 (100%)
$37.66 (30.78%)
511
Buy
$147
$-53.86 (-26.81%)
$135
1 years 10 days ago
(07-Nov-2024)
2/2 (100%)
$25.75 (21.24%)
280
What is LGND (Ligand Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on LGND (Ligand Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on LGND (Ligand Pharmaceuticals)?
Which analyst is the currently most bullish on LGND (Ligand Pharmaceuticals)?
Which analyst is the currently most reserved on LGND (Ligand Pharmaceuticals)?
